ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial

P.G. de Jong, S. Quenby, K.W.M. Bloemenkamp, B.A.M. Braams-Lisman, J.P. de Bruin, A. Coomarasamy, M. David, M.T. DeSancho, O.W.H. van der Heijden, A. van Hoek, B.A. Hutten, K. Jochmans, C.A.M. Koks, W.K.H. Kuchenbecker, B.J. Mol, H.L. Torrance, H.C.J. Scheepers, M.D. Stephenson, H.R. Verhoeve, J. VisserJ.I.P. Vries, M. Goddijn, S. Middeldorp

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)208
JournalTrials
Volume16
DOIs
Publication statusPublished - 2015

Cite this

de Jong, P. G., Quenby, S., Bloemenkamp, K. W. M., Braams-Lisman, B. A. M., de Bruin, J. P., Coomarasamy, A., ... Middeldorp, S. (2015). ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial. Trials, 16, 208. https://doi.org/10.1186/s13063-015-0719-9